Biontech (BNTX)Flossbach von Storch SE reduced its stake -1.45M shares

2.23M

Shares reported · -1.45M vs prior quarter

0.94%

Disclosed portfolio weight

$207M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

1. Oct 8, 2026InsiderCEO sold ~$2.49M of BNTX shares in the open market
2. Oct 9, 2026InsiderCEO sold ~$3.45M of BNTX shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Biontech

For Biontech, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BNTX page.

How this filing works

• SEC Form 13F

Other disclosures at Biontech

• SEC Form 4Oct 9, 2026
• SEC Form 4Oct 9, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 22, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its BNTX page.